RxDoctor Payments Data

Susan Hull, DO

Family Medicine · Grover, MONPI 1265408926

Payments from drug & device makers

$2,309in general payments, 2019–2025

Across 130 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$403
  • Novo Nordisk$311
  • Lilly USA, LLC$190
  • AstraZeneca$177
  • Pfizer$171
  • Merck$165
  • plus $892 from 20 others

What the payments were for

  • Food & beverage$2,22396%
  • Other$854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,309 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$55,275
Medicare patients
184
Services billed
580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$87,482
EliquisApixaban59$54,258
FarxigaDapagliflozin Propanediol47$47,406
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$26,925
MounjaroTirzepatide24$25,276
JardianceEmpagliflozin17$15,070
ArexvyRsvpref3 Antigen/As01e/Pf32$8,318
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,574
SymbicortBudesonide/Formoterol Fumarate18$4,122
Levemir FlexpenInsulin Detemir14$2,991
Atorvastatin Calcium316$2,435
SynthroidLevothyroxine Sodium45$2,398
Rosuvastatin Calcium284$2,280
Levothyroxine Sodium301$1,815
Gabapentin85$1,706

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$311$87,48253 claims
PfizerEliquis$171$54,25859 claims
AstraZenecaFarxiga, Symbicort$177$51,52865 claims
GSKTrelegy Ellipta, Arexvy, Anoro Ellipta$144$41,81778 claims
Lilly USA, LLCMounjaro$190$25,27624 claims
Boehringer IngelheimJardiance$42$15,07017 claims
AbbVieSynthroid$403$2,39845 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Grover

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →